id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-340314-5oz3013n	Mazzitelli, Maria	Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia	2020-05-15		.txt	text/plain	637	48	53	title: Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia We report herein a case series of patients with COVID‐19 pneumonia who were treated with tocilizumab administrated, for the first time, subcutaneously with good clinical and radiological outcomes. We have treated three patients with this drug at a single dose of 162 mg given subcutaneously, in line with data showing similar efficacy compared to This article is protected by copyright. Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection Tocilizumab treatment in COVID-19: A single center experience First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD Letter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab	./cache/cord-340314-5oz3013n.txt	./txt/cord-340314-5oz3013n.txt